loading page

Targeted treatment in viral associated inflammatory cardiomyopathy
  • +3
  • Ahmad Amin,
  • Sepideh Taghavi,
  • Maryam Chenaghlou,
  • Elahe Zare,
  • Monireh Kamali,
  • Nasim Naderi
Ahmad Amin
Rajaie Cardiovascular Medical and Research Center

Corresponding Author:[email protected]

Author Profile
Sepideh Taghavi
Rajaie Cardiovascular Medical and Research Center
Author Profile
Maryam Chenaghlou
Tabriz University of Medical Sciences
Author Profile
Elahe Zare
Yazd Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Author Profile
Monireh Kamali
Iran University of Medical Sciences
Author Profile
Nasim Naderi
Iran University of Medical Sciences
Author Profile

Abstract

Though generally self-limited, viral myocarditis can lead to acute cardiac failure or chronic dilated cardiomyopathy. We describe three cases of human herpes virus 6 (HHV6) associated -myocarditis unresponsive to conventional therapies, with detection of HHV-6 evidences and initiation of antiviral treatment, we observed significant improvement in clinical status of patients.
30 Mar 2021Submitted to Clinical Case Reports
02 Apr 2021Submission Checks Completed
02 Apr 2021Assigned to Editor
10 Apr 2021Reviewer(s) Assigned
20 Apr 2021Review(s) Completed, Editorial Evaluation Pending
20 Apr 2021Editorial Decision: Revise Minor
14 May 20211st Revision Received
17 May 2021Submission Checks Completed
17 May 2021Assigned to Editor
17 May 2021Review(s) Completed, Editorial Evaluation Pending
09 Jun 2021Editorial Decision: Accept